Developed to serve primarily as a litigation scouting report for plaintiff and defense counsel, insurers and legal service providers, HarrisMartin’s MDL Mass Tort & Class Action Monitor covers significant new filings and decisions in the JPML, MDL and related mass tort arenas. The quick delivery of breaking news and additional features will keep you within close range of every development occurring in the high-stakes environment of mass torts litigation — where minutes can make a difference. The MDL Mass Tort & Class Action Monitor is an online-only offering that includes frequent email updates and is available at no charge to annual and event sponsors of HarrisMartin’s CLE Conferences.
Download a publication order form here or subscribe here.
MDL Mass Tort & Class Action Monitor - Issue: 50
Valsartan Plaintiffs Urge Judge to Reject ZHP’s Appeal in Amendment Dispute
Merck Says All Gardasil MDL Claims Preempted by Vaccine Act
Plaintiffs Must Produce PICA Diagnosis in Taxotere MDL, Judge Rules
Hawaii Awarded $916 Million in Plavix Failure-To-Warn Case
SnapChat Hit With Wrongful Death Action Following Teen’s Suicide
Judge Greenlights $5 Million in Attorneys’ Fees in Thyroid Drug Class Action
Valisure Accuses GSK of Defrauding Government by Selling Contaminated Zantac
Plaintiffs’ Leadership Appointed in Baby Food Heavy Metals MDL
